Kuno Toshiya, Hirose Yoshinobu, Yamada Yasuhiro, Imaida Katsumi, Tatematsu Kenjiro, Mori Yukio, Mori Hideki
Department of Tumor Pathology, Graduate School of Medicine, Gifu University, Gifu 501-1194.
Oncol Lett. 2010 Mar;1(2):273-278. doi: 10.3892/ol_00000048. Epub 2010 Mar 1.
The preventive effects of dietary exposure to a wasabi derivative 6-methylsulfinylhexyl isothiocyanate (6-MSITC) during the initiation and post-initiation phases on the development of 1,2-dimethylhydrazine (DMH)-induced colonic aberrant crypt foci (ACF), and β-catenin-accumulated crypts (BCAC) were investigated in male F344 rats. To induce ACF and BCAC, rats were given four weekly subcutaneous injections of DMH (40 mg/kg body weight). The rats also received diets containing 200 or 400 ppm 6-MSITC during the initiation or post-initiation phases. The experiment was terminated 12 weeks after the start. DMH exposure produced a substantial number of ACF (323.8±69.7/colon) and BCAC (3.80±1.05/cm(2)) at the end of the study. Dietary administration of 6-MSITC at a dose of 400 ppm during the initiation phase caused a significant reduction in the total number of ACF (52% reduction, P<0.0001), larger ACF (4 or more crypt ACF) (58% reduction, P<0.001) and BCAC (76% reduction, P<0.00001). The dietary exposure to 6-MSITC significantly reduced the size (crypt multiplicity) of BCAC during both initiation and post-initiation treatment when compared to group 1 treated with DMH alone. Immunohistochemically, 6-MSITC administration lowered the proliferating cell nuclear antigen labeling index in ACF and BCAC. In addition, protein levels of hepatic cytochrome P-450 isozymes at 24 h after 6-MSITC exposure were significantly suppressed (P<0.01). The results indicated that 6-MSITC exerted chemopreventive effects in the present short-term colon carcinogenesis bioassay, through alterations in cell proliferation activity and drug metabolizing enzyme levels.
在雄性F344大鼠中,研究了在起始阶段和起始后阶段饮食中摄入芥末衍生的6-甲基亚磺酰基己基异硫氰酸酯(6-MSITC)对1,2-二甲基肼(DMH)诱导的结肠异常隐窝灶(ACF)和β-连环蛋白积聚隐窝(BCAC)发生发展的预防作用。为诱导ACF和BCAC,给大鼠每周皮下注射4次DMH(40mg/kg体重)。大鼠在起始阶段或起始后阶段还接受含200或400ppm 6-MSITC的饮食。实验在开始12周后结束。在研究结束时,DMH暴露产生了大量的ACF(323.8±69.7/结肠)和BCAC(3.80±1.05/cm²)。在起始阶段给予400ppm剂量的6-MSITC饮食导致ACF总数显著减少(减少52%,P<0.0001),较大的ACF(4个或更多隐窝ACF)(减少58%,P<0.001)和BCAC(减少76%,P<0.00001)。与仅用DMH处理的第1组相比,在起始阶段和起始后处理期间,饮食中摄入6-MSITC均显著减小了BCAC的大小(隐窝多倍性)。免疫组织化学分析显示,给予6-MSITC可降低ACF和BCAC中增殖细胞核抗原标记指数。此外,6-MSITC暴露24小时后,肝脏细胞色素P-450同工酶的蛋白水平受到显著抑制(P<0.01)。结果表明,在本短期结肠癌发生生物测定中,6-MSITC通过改变细胞增殖活性和药物代谢酶水平发挥了化学预防作用。